# The Effect of Empagliflozin on NAFLD in Asian Patients With Type 2 Diabetes

> **NCT02964715** · PHASE4 · UNKNOWN · sponsor: **University of Malaya** · enrollment: 25 (estimated)

## Conditions studied

- Type2 Diabetes
- NAFLD

## Interventions

- **DRUG:** Empagliflozin

## Key facts

- **NCT ID:** NCT02964715
- **Lead sponsor:** University of Malaya
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-11
- **Primary completion:** 2018-11
- **Final completion:** 2018-11
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2017-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02964715

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02964715, "The Effect of Empagliflozin on NAFLD in Asian Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT02964715. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*